Compare CNTY & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTY | VERU |
|---|---|---|
| Founded | 1992 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 39.8M |
| IPO Year | 1993 | 1990 |
| Metric | CNTY | VERU |
|---|---|---|
| Price | $1.34 | $2.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $4.00 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 191.6K | 183.3K |
| Earning Date | 11-10-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $572,756,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $7.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $2.11 |
| 52 Week High | $3.31 | $14.20 |
| Indicator | CNTY | VERU |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 36.23 |
| Support Level | $1.31 | $2.23 |
| Resistance Level | $1.47 | $2.42 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 45.12 | 13.30 |
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.